Harvey Norman Holdings Limited
Harvey Norman Holdings Limited (HNORY) Stock Competitors & Peer Comparison
See (HNORY) competitors and their performances in Stock Market.
Peer Comparison Table: Specialty Retail Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HNORY | $12.50 | +0.00% | 3.1B | 11.06 | $1.13 | +6.19% |
| BABAF | $15.82 | +3.50% | 301.8B | 17.01 | $0.93 | +1.58% |
| MPNGF | $17.60 | +6.67% | 107.5B | 22.28 | $0.79 | N/A |
| MPNGY | $33.05 | -2.71% | 101.4B | 20.92 | $1.58 | N/A |
| ANCTF | $54.25 | -1.40% | 51.6B | 20.08 | $2.71 | +1.00% |
| JDCMF | $16.88 | +0.03% | 48.7B | 8.19 | $2.06 | +2.96% |
| YAHOY | $7.70 | +1.18% | 26.7B | 27.21 | $0.28 | N/A |
| XXLLY | $739.00 | +0.00% | 23.4B | -100.00 | -$7.39 | N/A |
| MTTRY | $0.98 | +3.07% | 11.9B | -48.95 | -$0.02 | N/A |
| RKUNF | $5.34 | -1.66% | 11.6B | -8.75 | -$0.61 | N/A |
Stock Comparison
HNORY vs BABAF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, BABAF has a market cap of 301.8B. Regarding current trading prices, HNORY is priced at $12.50, while BABAF trades at $15.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas BABAF's P/E ratio is 17.01. In terms of profitability, HNORY's ROE is +0.08%, compared to BABAF's ROE of +0.12%. Regarding short-term risk, HNORY is less volatile compared to BABAF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check BABAF's competition here
HNORY vs MPNGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MPNGF has a market cap of 107.5B. Regarding current trading prices, HNORY is priced at $12.50, while MPNGF trades at $17.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MPNGF's P/E ratio is 22.28. In terms of profitability, HNORY's ROE is +0.08%, compared to MPNGF's ROE of +0.10%. Regarding short-term risk, HNORY and MPNGF have similar daily volatility (0.00).Check MPNGF's competition here
HNORY vs MPNGY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MPNGY has a market cap of 101.4B. Regarding current trading prices, HNORY is priced at $12.50, while MPNGY trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MPNGY's P/E ratio is 20.92. In terms of profitability, HNORY's ROE is +0.08%, compared to MPNGY's ROE of +0.10%. Regarding short-term risk, HNORY is less volatile compared to MPNGY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MPNGY's competition here
HNORY vs ANCTF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ANCTF has a market cap of 51.6B. Regarding current trading prices, HNORY is priced at $12.50, while ANCTF trades at $54.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ANCTF's P/E ratio is 20.08. In terms of profitability, HNORY's ROE is +0.08%, compared to ANCTF's ROE of +0.18%. Regarding short-term risk, HNORY is less volatile compared to ANCTF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ANCTF's competition here
HNORY vs JDCMF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JDCMF has a market cap of 48.7B. Regarding current trading prices, HNORY is priced at $12.50, while JDCMF trades at $16.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JDCMF's P/E ratio is 8.19. In terms of profitability, HNORY's ROE is +0.08%, compared to JDCMF's ROE of +0.20%. Regarding short-term risk, HNORY and JDCMF have similar daily volatility (0.00).Check JDCMF's competition here
HNORY vs YAHOY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, YAHOY has a market cap of 26.7B. Regarding current trading prices, HNORY is priced at $12.50, while YAHOY trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas YAHOY's P/E ratio is 27.21. In terms of profitability, HNORY's ROE is +0.08%, compared to YAHOY's ROE of +0.05%. Regarding short-term risk, HNORY is less volatile compared to YAHOY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check YAHOY's competition here
HNORY vs XXLLY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, XXLLY has a market cap of 23.4B. Regarding current trading prices, HNORY is priced at $12.50, while XXLLY trades at $739.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas XXLLY's P/E ratio is -100.00. In terms of profitability, HNORY's ROE is +0.08%, compared to XXLLY's ROE of -0.97%. Regarding short-term risk, HNORY is less volatile compared to XXLLY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check XXLLY's competition here
HNORY vs MTTRY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MTTRY has a market cap of 11.9B. Regarding current trading prices, HNORY is priced at $12.50, while MTTRY trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MTTRY's P/E ratio is -48.95. In terms of profitability, HNORY's ROE is +0.08%, compared to MTTRY's ROE of -0.08%. Regarding short-term risk, HNORY is less volatile compared to MTTRY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MTTRY's competition here
HNORY vs RKUNF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, RKUNF has a market cap of 11.6B. Regarding current trading prices, HNORY is priced at $12.50, while RKUNF trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas RKUNF's P/E ratio is -8.75. In terms of profitability, HNORY's ROE is +0.08%, compared to RKUNF's ROE of -0.24%. Regarding short-term risk, HNORY and RKUNF have similar daily volatility (0.00).Check RKUNF's competition here
HNORY vs RKUNY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, RKUNY has a market cap of 11.4B. Regarding current trading prices, HNORY is priced at $12.50, while RKUNY trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas RKUNY's P/E ratio is -8.70. In terms of profitability, HNORY's ROE is +0.08%, compared to RKUNY's ROE of -0.19%. Regarding short-term risk, HNORY is less volatile compared to RKUNY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check RKUNY's competition here
HNORY vs NCLTY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, NCLTY has a market cap of 9.9B. Regarding current trading prices, HNORY is priced at $12.50, while NCLTY trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas NCLTY's P/E ratio is -79.73. In terms of profitability, HNORY's ROE is +0.08%, compared to NCLTY's ROE of +0.10%. Regarding short-term risk, HNORY is less volatile compared to NCLTY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check NCLTY's competition here
HNORY vs NCLTF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, NCLTF has a market cap of 9.9B. Regarding current trading prices, HNORY is priced at $12.50, while NCLTF trades at $87.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas NCLTF's P/E ratio is -76.04. In terms of profitability, HNORY's ROE is +0.08%, compared to NCLTF's ROE of +0.10%. Regarding short-term risk, HNORY and NCLTF have similar daily volatility (0.00).Check NCLTF's competition here
HNORY vs DELHY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DELHY has a market cap of 9.5B. Regarding current trading prices, HNORY is priced at $12.50, while DELHY trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DELHY's P/E ratio is -8.97. In terms of profitability, HNORY's ROE is +0.08%, compared to DELHY's ROE of -0.46%. Regarding short-term risk, HNORY is less volatile compared to DELHY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check DELHY's competition here
HNORY vs SNROF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SNROF has a market cap of 9.5B. Regarding current trading prices, HNORY is priced at $12.50, while SNROF trades at $40.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SNROF's P/E ratio is 35.09. In terms of profitability, HNORY's ROE is +0.08%, compared to SNROF's ROE of +0.47%. Regarding short-term risk, HNORY and SNROF have similar daily volatility (0.00).Check SNROF's competition here
HNORY vs HKTGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, HKTGF has a market cap of 9.4B. Regarding current trading prices, HNORY is priced at $12.50, while HKTGF trades at $215.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas HKTGF's P/E ratio is 9.00. In terms of profitability, HNORY's ROE is +0.08%, compared to HKTGF's ROE of +0.13%. Regarding short-term risk, HNORY and HKTGF have similar daily volatility (0.00).Check HKTGF's competition here
HNORY vs MONOY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MONOY has a market cap of 9.2B. Regarding current trading prices, HNORY is priced at $12.50, while MONOY trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MONOY's P/E ratio is 48.49. In terms of profitability, HNORY's ROE is +0.08%, compared to MONOY's ROE of +0.27%. Regarding short-term risk, HNORY is less volatile compared to MONOY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MONOY's competition here
HNORY vs SRTTY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SRTTY has a market cap of 9.1B. Regarding current trading prices, HNORY is priced at $12.50, while SRTTY trades at $9.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SRTTY's P/E ratio is 27.26. In terms of profitability, HNORY's ROE is +0.08%, compared to SRTTY's ROE of +0.56%. Regarding short-term risk, HNORY and SRTTY have similar daily volatility (0.00).Check SRTTY's competition here
HNORY vs SATLF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SATLF has a market cap of 9.1B. Regarding current trading prices, HNORY is priced at $12.50, while SATLF trades at $10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SATLF's P/E ratio is 30.37. In terms of profitability, HNORY's ROE is +0.08%, compared to SATLF's ROE of +0.51%. Regarding short-term risk, HNORY and SATLF have similar daily volatility (0.00).Check SATLF's competition here
HNORY vs ZLNDY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ZLNDY has a market cap of 8.3B. Regarding current trading prices, HNORY is priced at $12.50, while ZLNDY trades at $16.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ZLNDY's P/E ratio is 26.70. In terms of profitability, HNORY's ROE is +0.08%, compared to ZLNDY's ROE of +0.10%. Regarding short-term risk, HNORY is less volatile compared to ZLNDY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ZLNDY's competition here
HNORY vs ZLDSF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ZLDSF has a market cap of 8.2B. Regarding current trading prices, HNORY is priced at $12.50, while ZLDSF trades at $31.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ZLDSF's P/E ratio is 26.25. In terms of profitability, HNORY's ROE is +0.08%, compared to ZLDSF's ROE of +0.10%. Regarding short-term risk, HNORY and ZLDSF have similar daily volatility (0.00).Check ZLDSF's competition here
HNORY vs ALEGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ALEGF has a market cap of 8.1B. Regarding current trading prices, HNORY is priced at $12.50, while ALEGF trades at $7.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ALEGF's P/E ratio is 27.32. In terms of profitability, HNORY's ROE is +0.08%, compared to ALEGF's ROE of +0.11%. Regarding short-term risk, HNORY is less volatile compared to ALEGF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ALEGF's competition here
HNORY vs DUFRY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DUFRY has a market cap of 7.8B. Regarding current trading prices, HNORY is priced at $12.50, while DUFRY trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DUFRY's P/E ratio is 59.53. In terms of profitability, HNORY's ROE is +0.08%, compared to DUFRY's ROE of +0.05%. Regarding short-term risk, HNORY and DUFRY have similar daily volatility (0.00).Check DUFRY's competition here
HNORY vs CDNAF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, CDNAF has a market cap of 7.6B. Regarding current trading prices, HNORY is priced at $12.50, while CDNAF trades at $138.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas CDNAF's P/E ratio is 12.26. In terms of profitability, HNORY's ROE is +0.08%, compared to CDNAF's ROE of +0.14%. Regarding short-term risk, HNORY is less volatile compared to CDNAF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check CDNAF's competition here
HNORY vs CDNTF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, CDNTF has a market cap of 7.6B. Regarding current trading prices, HNORY is priced at $12.50, while CDNTF trades at $190.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas CDNTF's P/E ratio is 16.92. In terms of profitability, HNORY's ROE is +0.08%, compared to CDNTF's ROE of +0.14%. Regarding short-term risk, HNORY and CDNTF have similar daily volatility (0.00).Check CDNTF's competition here
HNORY vs DLVHF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DLVHF has a market cap of 7.5B. Regarding current trading prices, HNORY is priced at $12.50, while DLVHF trades at $25.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DLVHF's P/E ratio is -6.99. In terms of profitability, HNORY's ROE is +0.08%, compared to DLVHF's ROE of -0.46%. Regarding short-term risk, HNORY is less volatile compared to DLVHF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check DLVHF's competition here
HNORY vs DFRYF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DFRYF has a market cap of 7.5B. Regarding current trading prices, HNORY is priced at $12.50, while DFRYF trades at $51.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DFRYF's P/E ratio is 60.07. In terms of profitability, HNORY's ROE is +0.08%, compared to DFRYF's ROE of +0.03%. Regarding short-term risk, HNORY and DFRYF have similar daily volatility (0.00).Check DFRYF's competition here
HNORY vs PETRY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, PETRY has a market cap of 7.5B. Regarding current trading prices, HNORY is priced at $12.50, while PETRY trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas PETRY's P/E ratio is 3.46. In terms of profitability, HNORY's ROE is +0.08%, compared to PETRY's ROE of +0.32%. Regarding short-term risk, HNORY is less volatile compared to PETRY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check PETRY's competition here
HNORY vs JBHIF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JBHIF has a market cap of 7.3B. Regarding current trading prices, HNORY is priced at $12.50, while JBHIF trades at $66.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JBHIF's P/E ratio is 24.30. In terms of profitability, HNORY's ROE is +0.08%, compared to JBHIF's ROE of +0.28%. Regarding short-term risk, HNORY is less volatile compared to JBHIF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check JBHIF's competition here
HNORY vs ELPQF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ELPQF has a market cap of 7.1B. Regarding current trading prices, HNORY is priced at $12.50, while ELPQF trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ELPQF's P/E ratio is 5.57. In terms of profitability, HNORY's ROE is +0.08%, compared to ELPQF's ROE of +0.14%. Regarding short-term risk, HNORY and ELPQF have similar daily volatility (0.00).Check ELPQF's competition here
HNORY vs MONOF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MONOF has a market cap of 7B. Regarding current trading prices, HNORY is priced at $12.50, while MONOF trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MONOF's P/E ratio is 36.33. In terms of profitability, HNORY's ROE is +0.08%, compared to MONOF's ROE of +0.20%. Regarding short-term risk, HNORY is less volatile compared to MONOF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MONOF's competition here
HNORY vs JDSPY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JDSPY has a market cap of 6.3B. Regarding current trading prices, HNORY is priced at $12.50, while JDSPY trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JDSPY's P/E ratio is 9.54. In terms of profitability, HNORY's ROE is +0.08%, compared to JDSPY's ROE of +0.18%. Regarding short-term risk, HNORY is less volatile compared to JDSPY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check JDSPY's competition here
HNORY vs JDDSF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JDDSF has a market cap of 6.1B. Regarding current trading prices, HNORY is priced at $12.50, while JDDSF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JDDSF's P/E ratio is 9.23. In terms of profitability, HNORY's ROE is +0.08%, compared to JDDSF's ROE of +0.18%. Regarding short-term risk, HNORY is less volatile compared to JDDSF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check JDDSF's competition here
HNORY vs JUMSY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JUMSY has a market cap of 5.3B. Regarding current trading prices, HNORY is priced at $12.50, while JUMSY trades at $38.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JUMSY's P/E ratio is 14.00. In terms of profitability, HNORY's ROE is +0.08%, compared to JUMSY's ROE of +0.24%. Regarding short-term risk, HNORY and JUMSY have similar daily volatility (0.00).Check JUMSY's competition here
HNORY vs JTKWY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JTKWY has a market cap of 4.7B. Regarding current trading prices, HNORY is priced at $12.50, while JTKWY trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JTKWY's P/E ratio is -8.16. In terms of profitability, HNORY's ROE is +0.08%, compared to JTKWY's ROE of -0.37%. Regarding short-term risk, HNORY is less volatile compared to JTKWY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check JTKWY's competition here
HNORY vs TKAYF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, TKAYF has a market cap of 4.5B. Regarding current trading prices, HNORY is priced at $12.50, while TKAYF trades at $22.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas TKAYF's P/E ratio is -8.02. In terms of profitability, HNORY's ROE is +0.08%, compared to TKAYF's ROE of -0.37%. Regarding short-term risk, HNORY is less volatile compared to TKAYF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check TKAYF's competition here
HNORY vs SDIPF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SDIPF has a market cap of 4.1B. Regarding current trading prices, HNORY is priced at $12.50, while SDIPF trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SDIPF's P/E ratio is 10.60. In terms of profitability, HNORY's ROE is +0.08%, compared to SDIPF's ROE of +0.22%. Regarding short-term risk, HNORY is less volatile compared to SDIPF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check SDIPF's competition here
HNORY vs ZLPSF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ZLPSF has a market cap of 3.8B. Regarding current trading prices, HNORY is priced at $12.50, while ZLPSF trades at $536.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ZLPSF's P/E ratio is -623.70. In terms of profitability, HNORY's ROE is +0.08%, compared to ZLPSF's ROE of -0.13%. Regarding short-term risk, HNORY is less volatile compared to ZLPSF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ZLPSF's competition here
HNORY vs JUMSF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, JUMSF has a market cap of 3.7B. Regarding current trading prices, HNORY is priced at $12.50, while JUMSF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas JUMSF's P/E ratio is 11.51. In terms of profitability, HNORY's ROE is +0.08%, compared to JUMSF's ROE of +0.18%. Regarding short-term risk, HNORY and JUMSF have similar daily volatility (0.00).Check JUMSF's competition here
HNORY vs ZOPLY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ZOPLY has a market cap of 3.5B. Regarding current trading prices, HNORY is priced at $12.50, while ZOPLY trades at $122.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ZOPLY's P/E ratio is -210.38. In terms of profitability, HNORY's ROE is +0.08%, compared to ZOPLY's ROE of N/A. Regarding short-term risk, HNORY and ZOPLY have similar daily volatility (0.00).Check ZOPLY's competition here
HNORY vs DROOF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DROOF has a market cap of 3.5B. Regarding current trading prices, HNORY is priced at $12.50, while DROOF trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DROOF's P/E ratio is 60.25. In terms of profitability, HNORY's ROE is +0.08%, compared to DROOF's ROE of +0.11%. Regarding short-term risk, HNORY and DROOF have similar daily volatility (0.00).Check DROOF's competition here
HNORY vs DNLMY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DNLMY has a market cap of 3.2B. Regarding current trading prices, HNORY is priced at $12.50, while DNLMY trades at $16.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DNLMY's P/E ratio is 16.10. In terms of profitability, HNORY's ROE is +0.08%, compared to DNLMY's ROE of +0.97%. Regarding short-term risk, HNORY and DNLMY have similar daily volatility (0.00).Check DNLMY's competition here
HNORY vs MCARY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MCARY has a market cap of 2.8B. Regarding current trading prices, HNORY is priced at $12.50, while MCARY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MCARY's P/E ratio is 25.76. In terms of profitability, HNORY's ROE is +0.08%, compared to MCARY's ROE of +0.15%. Regarding short-term risk, HNORY is less volatile compared to MCARY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MCARY's competition here
HNORY vs MRCIF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MRCIF has a market cap of 2.6B. Regarding current trading prices, HNORY is priced at $12.50, while MRCIF trades at $15.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MRCIF's P/E ratio is 24.06. In terms of profitability, HNORY's ROE is +0.08%, compared to MRCIF's ROE of +0.15%. Regarding short-term risk, HNORY is less volatile compared to MRCIF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MRCIF's competition here
HNORY vs MTAGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MTAGF has a market cap of 2.4B. Regarding current trading prices, HNORY is priced at $12.50, while MTAGF trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MTAGF's P/E ratio is 29.18. In terms of profitability, HNORY's ROE is +0.08%, compared to MTAGF's ROE of -0.08%. Regarding short-term risk, HNORY is less volatile compared to MTAGF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MTAGF's competition here
HNORY vs YMDAF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, YMDAF has a market cap of 2.2B. Regarding current trading prices, HNORY is priced at $12.50, while YMDAF trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas YMDAF's P/E ratio is 12.15. In terms of profitability, HNORY's ROE is +0.08%, compared to YMDAF's ROE of +0.04%. Regarding short-term risk, HNORY and YMDAF have similar daily volatility (0.00).Check YMDAF's competition here
HNORY vs FHNGY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, FHNGY has a market cap of 2.1B. Regarding current trading prices, HNORY is priced at $12.50, while FHNGY trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas FHNGY's P/E ratio is 11.84. In terms of profitability, HNORY's ROE is +0.08%, compared to FHNGY's ROE of +0.12%. Regarding short-term risk, HNORY is less volatile compared to FHNGY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check FHNGY's competition here
HNORY vs WHTPF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, WHTPF has a market cap of 1.8B. Regarding current trading prices, HNORY is priced at $12.50, while WHTPF trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas WHTPF's P/E ratio is 235.67. In terms of profitability, HNORY's ROE is +0.08%, compared to WHTPF's ROE of +0.19%. Regarding short-term risk, HNORY and WHTPF have similar daily volatility (0.00).Check WHTPF's competition here
HNORY vs DSITF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, DSITF has a market cap of 1.7B. Regarding current trading prices, HNORY is priced at $12.50, while DSITF trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas DSITF's P/E ratio is 22.43. In terms of profitability, HNORY's ROE is +0.08%, compared to DSITF's ROE of +0.08%. Regarding short-term risk, HNORY is less volatile compared to DSITF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check DSITF's competition here
HNORY vs PAHGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, PAHGF has a market cap of 1.6B. Regarding current trading prices, HNORY is priced at $12.50, while PAHGF trades at $3.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas PAHGF's P/E ratio is 14.52. In terms of profitability, HNORY's ROE is +0.08%, compared to PAHGF's ROE of +0.09%. Regarding short-term risk, HNORY and PAHGF have similar daily volatility (0.00).Check PAHGF's competition here
HNORY vs BTOOY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, BTOOY has a market cap of 1.5B. Regarding current trading prices, HNORY is priced at $12.50, while BTOOY trades at $3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas BTOOY's P/E ratio is -23.63. In terms of profitability, HNORY's ROE is +0.08%, compared to BTOOY's ROE of +0.04%. Regarding short-term risk, HNORY and BTOOY have similar daily volatility (0.00).Check BTOOY's competition here
HNORY vs MIZUF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MIZUF has a market cap of 1.5B. Regarding current trading prices, HNORY is priced at $12.50, while MIZUF trades at $19.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MIZUF's P/E ratio is 14.67. In terms of profitability, HNORY's ROE is +0.08%, compared to MIZUF's ROE of +0.10%. Regarding short-term risk, HNORY and MIZUF have similar daily volatility (0.00).Check MIZUF's competition here
HNORY vs GPGNF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, GPGNF has a market cap of 1.4B. Regarding current trading prices, HNORY is priced at $12.50, while GPGNF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas GPGNF's P/E ratio is 16.11. In terms of profitability, HNORY's ROE is +0.08%, compared to GPGNF's ROE of +0.09%. Regarding short-term risk, HNORY is less volatile compared to GPGNF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check GPGNF's competition here
HNORY vs LEFUF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, LEFUF has a market cap of 1.4B. Regarding current trading prices, HNORY is priced at $12.50, while LEFUF trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas LEFUF's P/E ratio is 11.85. In terms of profitability, HNORY's ROE is +0.08%, compared to LEFUF's ROE of +0.14%. Regarding short-term risk, HNORY and LEFUF have similar daily volatility (0.00).Check LEFUF's competition here
HNORY vs MKRMF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MKRMF has a market cap of 1B. Regarding current trading prices, HNORY is priced at $12.50, while MKRMF trades at $235.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MKRMF's P/E ratio is -136.63. In terms of profitability, HNORY's ROE is +0.08%, compared to MKRMF's ROE of N/A. Regarding short-term risk, HNORY and MKRMF have similar daily volatility (0.00).Check MKRMF's competition here
HNORY vs MGLUY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MGLUY has a market cap of 1B. Regarding current trading prices, HNORY is priced at $12.50, while MGLUY trades at $5.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MGLUY's P/E ratio is 13.27. In terms of profitability, HNORY's ROE is +0.08%, compared to MGLUY's ROE of +0.04%. Regarding short-term risk, HNORY is less volatile compared to MGLUY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check MGLUY's competition here
HNORY vs GRUPF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, GRUPF has a market cap of 1B. Regarding current trading prices, HNORY is priced at $12.50, while GRUPF trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas GRUPF's P/E ratio is 15.90. In terms of profitability, HNORY's ROE is +0.08%, compared to GRUPF's ROE of +0.07%. Regarding short-term risk, HNORY and GRUPF have similar daily volatility (0.00).Check GRUPF's competition here
HNORY vs FNXTF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, FNXTF has a market cap of 987.2M. Regarding current trading prices, HNORY is priced at $12.50, while FNXTF trades at $74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas FNXTF's P/E ratio is 13.70. In terms of profitability, HNORY's ROE is +0.08%, compared to FNXTF's ROE of +0.02%. Regarding short-term risk, HNORY is less volatile compared to FNXTF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check FNXTF's competition here
HNORY vs SCCAF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SCCAF has a market cap of 875M. Regarding current trading prices, HNORY is priced at $12.50, while SCCAF trades at $25.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SCCAF's P/E ratio is 16.76. In terms of profitability, HNORY's ROE is +0.08%, compared to SCCAF's ROE of +0.11%. Regarding short-term risk, HNORY and SCCAF have similar daily volatility (0.00).Check SCCAF's competition here
HNORY vs THGPF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, THGPF has a market cap of 644M. Regarding current trading prices, HNORY is priced at $12.50, while THGPF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas THGPF's P/E ratio is -2.57. In terms of profitability, HNORY's ROE is +0.08%, compared to THGPF's ROE of -0.48%. Regarding short-term risk, HNORY and THGPF have similar daily volatility (0.00).Check THGPF's competition here
HNORY vs HWGC Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, HWGC has a market cap of 596.2M. Regarding current trading prices, HNORY is priced at $12.50, while HWGC trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas HWGC's P/E ratio is 100.00. In terms of profitability, HNORY's ROE is +0.08%, compared to HWGC's ROE of -0.04%. Regarding short-term risk, HNORY and HWGC have similar daily volatility (0.00).Check HWGC's competition here
HNORY vs THGHY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, THGHY has a market cap of 591.2M. Regarding current trading prices, HNORY is priced at $12.50, while THGHY trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas THGHY's P/E ratio is -2.36. In terms of profitability, HNORY's ROE is +0.08%, compared to THGHY's ROE of -0.39%. Regarding short-term risk, HNORY is less volatile compared to THGHY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check THGHY's competition here
HNORY vs ASOMY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ASOMY has a market cap of 585.2M. Regarding current trading prices, HNORY is priced at $12.50, while ASOMY trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ASOMY's P/E ratio is -1.47. In terms of profitability, HNORY's ROE is +0.08%, compared to ASOMY's ROE of -0.49%. Regarding short-term risk, HNORY and ASOMY have similar daily volatility (0.00).Check ASOMY's competition here
HNORY vs HLFDF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, HLFDF has a market cap of 463.1M. Regarding current trading prices, HNORY is priced at $12.50, while HLFDF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas HLFDF's P/E ratio is -10.10. In terms of profitability, HNORY's ROE is +0.08%, compared to HLFDF's ROE of +0.03%. Regarding short-term risk, HNORY and HLFDF have similar daily volatility (0.00).Check HLFDF's competition here
HNORY vs KGGNF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, KGGNF has a market cap of 442M. Regarding current trading prices, HNORY is priced at $12.50, while KGGNF trades at $4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas KGGNF's P/E ratio is 111.25. In terms of profitability, HNORY's ROE is +0.08%, compared to KGGNF's ROE of +0.00%. Regarding short-term risk, HNORY and KGGNF have similar daily volatility (0.00).Check KGGNF's competition here
HNORY vs HLFDY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, HLFDY has a market cap of 425.9M. Regarding current trading prices, HNORY is priced at $12.50, while HLFDY trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas HLFDY's P/E ratio is -9.29. In terms of profitability, HNORY's ROE is +0.08%, compared to HLFDY's ROE of +0.03%. Regarding short-term risk, HNORY is less volatile compared to HLFDY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check HLFDY's competition here
HNORY vs ASOMF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ASOMF has a market cap of 421.3M. Regarding current trading prices, HNORY is priced at $12.50, while ASOMF trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ASOMF's P/E ratio is -1.04. In terms of profitability, HNORY's ROE is +0.08%, compared to ASOMF's ROE of -0.49%. Regarding short-term risk, HNORY is less volatile compared to ASOMF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ASOMF's competition here
HNORY vs CRFCF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, CRFCF has a market cap of 402.5M. Regarding current trading prices, HNORY is priced at $12.50, while CRFCF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas CRFCF's P/E ratio is 6.05. In terms of profitability, HNORY's ROE is +0.08%, compared to CRFCF's ROE of +0.13%. Regarding short-term risk, HNORY and CRFCF have similar daily volatility (0.00).Check CRFCF's competition here
HNORY vs KTYCF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, KTYCF has a market cap of 384.1M. Regarding current trading prices, HNORY is priced at $12.50, while KTYCF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas KTYCF's P/E ratio is 120.00. In terms of profitability, HNORY's ROE is +0.08%, compared to KTYCF's ROE of +0.08%. Regarding short-term risk, HNORY and KTYCF have similar daily volatility (0.00).Check KTYCF's competition here
HNORY vs SSILF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SSILF has a market cap of 370.5M. Regarding current trading prices, HNORY is priced at $12.50, while SSILF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SSILF's P/E ratio is 11.94. In terms of profitability, HNORY's ROE is +0.08%, compared to SSILF's ROE of +0.19%. Regarding short-term risk, HNORY and SSILF have similar daily volatility (0.00).Check SSILF's competition here
HNORY vs GMELF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, GMELF has a market cap of 345.4M. Regarding current trading prices, HNORY is priced at $12.50, while GMELF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas GMELF's P/E ratio is -0.24. In terms of profitability, HNORY's ROE is +0.08%, compared to GMELF's ROE of +0.86%. Regarding short-term risk, HNORY and GMELF have similar daily volatility (0.00).Check GMELF's competition here
HNORY vs BHOOY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, BHOOY has a market cap of 307.7M. Regarding current trading prices, HNORY is priced at $12.50, while BHOOY trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas BHOOY's P/E ratio is -0.87. In terms of profitability, HNORY's ROE is +0.08%, compared to BHOOY's ROE of -1.19%. Regarding short-term risk, HNORY is less volatile compared to BHOOY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check BHOOY's competition here
HNORY vs BHHOF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, BHHOF has a market cap of 302.5M. Regarding current trading prices, HNORY is priced at $12.50, while BHHOF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas BHHOF's P/E ratio is -0.87. In terms of profitability, HNORY's ROE is +0.08%, compared to BHHOF's ROE of -0.41%. Regarding short-term risk, HNORY and BHHOF have similar daily volatility (0.00).Check BHHOF's competition here
HNORY vs NBRNF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, NBRNF has a market cap of 251.3M. Regarding current trading prices, HNORY is priced at $12.50, while NBRNF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas NBRNF's P/E ratio is 53.84. In terms of profitability, HNORY's ROE is +0.08%, compared to NBRNF's ROE of +0.01%. Regarding short-term risk, HNORY is less volatile compared to NBRNF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check NBRNF's competition here
HNORY vs HMAGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, HMAGF has a market cap of 246.4M. Regarding current trading prices, HNORY is priced at $12.50, while HMAGF trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas HMAGF's P/E ratio is -4.68. In terms of profitability, HNORY's ROE is +0.08%, compared to HMAGF's ROE of -0.24%. Regarding short-term risk, HNORY and HMAGF have similar daily volatility (0.00).Check HMAGF's competition here
HNORY vs SAXJY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SAXJY has a market cap of 197M. Regarding current trading prices, HNORY is priced at $12.50, while SAXJY trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SAXJY's P/E ratio is 21.17. In terms of profitability, HNORY's ROE is +0.08%, compared to SAXJY's ROE of +0.19%. Regarding short-term risk, HNORY is less volatile compared to SAXJY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check SAXJY's competition here
HNORY vs HKTVY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, HKTVY has a market cap of 166.5M. Regarding current trading prices, HNORY is priced at $12.50, while HKTVY trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas HKTVY's P/E ratio is -21.10. In terms of profitability, HNORY's ROE is +0.08%, compared to HKTVY's ROE of -0.02%. Regarding short-term risk, HNORY and HKTVY have similar daily volatility (0.00).Check HKTVY's competition here
HNORY vs YUMSF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, YUMSF has a market cap of 153M. Regarding current trading prices, HNORY is priced at $12.50, while YUMSF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas YUMSF's P/E ratio is -11.42. In terms of profitability, HNORY's ROE is +0.08%, compared to YUMSF's ROE of -0.07%. Regarding short-term risk, HNORY and YUMSF have similar daily volatility (0.00).Check YUMSF's competition here
HNORY vs RDBBY Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, RDBBY has a market cap of 129.2M. Regarding current trading prices, HNORY is priced at $12.50, while RDBBY trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas RDBBY's P/E ratio is -2.17. In terms of profitability, HNORY's ROE is +0.08%, compared to RDBBY's ROE of -0.22%. Regarding short-term risk, HNORY is less volatile compared to RDBBY. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check RDBBY's competition here
HNORY vs WCRS Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, WCRS has a market cap of 118.9M. Regarding current trading prices, HNORY is priced at $12.50, while WCRS trades at $13.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas WCRS's P/E ratio is 3.97. In terms of profitability, HNORY's ROE is +0.08%, compared to WCRS's ROE of +0.00%. Regarding short-term risk, HNORY is less volatile compared to WCRS. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check WCRS's competition here
HNORY vs BNNNF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, BNNNF has a market cap of 118.6M. Regarding current trading prices, HNORY is priced at $12.50, while BNNNF trades at $9.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas BNNNF's P/E ratio is 9.73. In terms of profitability, HNORY's ROE is +0.08%, compared to BNNNF's ROE of +0.12%. Regarding short-term risk, HNORY is less volatile compared to BNNNF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check BNNNF's competition here
HNORY vs AHAHF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, AHAHF has a market cap of 116.1M. Regarding current trading prices, HNORY is priced at $12.50, while AHAHF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas AHAHF's P/E ratio is -160.00. In terms of profitability, HNORY's ROE is +0.08%, compared to AHAHF's ROE of +5.53%. Regarding short-term risk, HNORY is less volatile compared to AHAHF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check AHAHF's competition here
HNORY vs IGDFF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, IGDFF has a market cap of 73.4M. Regarding current trading prices, HNORY is priced at $12.50, while IGDFF trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas IGDFF's P/E ratio is 4.81. In terms of profitability, HNORY's ROE is +0.08%, compared to IGDFF's ROE of +0.06%. Regarding short-term risk, HNORY is less volatile compared to IGDFF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check IGDFF's competition here
HNORY vs MHCRF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, MHCRF has a market cap of 64.4M. Regarding current trading prices, HNORY is priced at $12.50, while MHCRF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas MHCRF's P/E ratio is 3.00. In terms of profitability, HNORY's ROE is +0.08%, compared to MHCRF's ROE of +0.67%. Regarding short-term risk, HNORY and MHCRF have similar daily volatility (0.00).Check MHCRF's competition here
HNORY vs SPGZ Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SPGZ has a market cap of 62.4M. Regarding current trading prices, HNORY is priced at $12.50, while SPGZ trades at $21,500.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SPGZ's P/E ratio is 15.75. In terms of profitability, HNORY's ROE is +0.08%, compared to SPGZ's ROE of +0.04%. Regarding short-term risk, Volatility data is not available for a full comparison. HNORY has daily volatility of 0.00 and SPGZ has daily volatility of N/A.Check SPGZ's competition here
HNORY vs ADBGF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ADBGF has a market cap of 61.1M. Regarding current trading prices, HNORY is priced at $12.50, while ADBGF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ADBGF's P/E ratio is 65.00. In terms of profitability, HNORY's ROE is +0.08%, compared to ADBGF's ROE of +0.06%. Regarding short-term risk, HNORY and ADBGF have similar daily volatility (0.00).Check ADBGF's competition here
HNORY vs ACEHF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ACEHF has a market cap of 59.9M. Regarding current trading prices, HNORY is priced at $12.50, while ACEHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ACEHF's P/E ratio is N/A. In terms of profitability, HNORY's ROE is +0.08%, compared to ACEHF's ROE of +0.13%. Regarding short-term risk, HNORY is less volatile compared to ACEHF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ACEHF's competition here
HNORY vs PXHI Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, PXHI has a market cap of 50.4M. Regarding current trading prices, HNORY is priced at $12.50, while PXHI trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas PXHI's P/E ratio is -2.35. In terms of profitability, HNORY's ROE is +0.08%, compared to PXHI's ROE of +0.15%. Regarding short-term risk, HNORY is less volatile compared to PXHI. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check PXHI's competition here
HNORY vs IDGBF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, IDGBF has a market cap of 50.4M. Regarding current trading prices, HNORY is priced at $12.50, while IDGBF trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas IDGBF's P/E ratio is -0.83. In terms of profitability, HNORY's ROE is +0.08%, compared to IDGBF's ROE of -12.64%. Regarding short-term risk, HNORY and IDGBF have similar daily volatility (0.00).Check IDGBF's competition here
HNORY vs TWRKF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, TWRKF has a market cap of 49.8M. Regarding current trading prices, HNORY is priced at $12.50, while TWRKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas TWRKF's P/E ratio is 0.13. In terms of profitability, HNORY's ROE is +0.08%, compared to TWRKF's ROE of +1.09%. Regarding short-term risk, HNORY and TWRKF have similar daily volatility (0.00).Check TWRKF's competition here
HNORY vs ARTZF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, ARTZF has a market cap of 41.4M. Regarding current trading prices, HNORY is priced at $12.50, while ARTZF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas ARTZF's P/E ratio is -48.33. In terms of profitability, HNORY's ROE is +0.08%, compared to ARTZF's ROE of -0.08%. Regarding short-term risk, HNORY is less volatile compared to ARTZF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check ARTZF's competition here
HNORY vs GLHD Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, GLHD has a market cap of 39.4M. Regarding current trading prices, HNORY is priced at $12.50, while GLHD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas GLHD's P/E ratio is 0.02. In terms of profitability, HNORY's ROE is +0.08%, compared to GLHD's ROE of N/A. Regarding short-term risk, HNORY is less volatile compared to GLHD. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check GLHD's competition here
HNORY vs CNVAF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, CNVAF has a market cap of 38M. Regarding current trading prices, HNORY is priced at $12.50, while CNVAF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas CNVAF's P/E ratio is -0.35. In terms of profitability, HNORY's ROE is +0.08%, compared to CNVAF's ROE of +0.13%. Regarding short-term risk, HNORY is less volatile compared to CNVAF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check CNVAF's competition here
HNORY vs RDBBF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, RDBBF has a market cap of 37.1M. Regarding current trading prices, HNORY is priced at $12.50, while RDBBF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas RDBBF's P/E ratio is -3.27. In terms of profitability, HNORY's ROE is +0.08%, compared to RDBBF's ROE of -0.15%. Regarding short-term risk, HNORY is less volatile compared to RDBBF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check RDBBF's competition here
HNORY vs FDIT Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, FDIT has a market cap of 30.1M. Regarding current trading prices, HNORY is priced at $12.50, while FDIT trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas FDIT's P/E ratio is N/A. In terms of profitability, HNORY's ROE is +0.08%, compared to FDIT's ROE of -4.62%. Regarding short-term risk, HNORY and FDIT have similar daily volatility (0.00).Check FDIT's competition here
HNORY vs SNHO Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, SNHO has a market cap of 20.5M. Regarding current trading prices, HNORY is priced at $12.50, while SNHO trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas SNHO's P/E ratio is -0.32. In terms of profitability, HNORY's ROE is +0.08%, compared to SNHO's ROE of -0.01%. Regarding short-term risk, HNORY is less volatile compared to SNHO. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check SNHO's competition here
HNORY vs RLAB Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, RLAB has a market cap of 19.4M. Regarding current trading prices, HNORY is priced at $12.50, while RLAB trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas RLAB's P/E ratio is N/A. In terms of profitability, HNORY's ROE is +0.08%, compared to RLAB's ROE of N/A. Regarding short-term risk, HNORY is less volatile compared to RLAB. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check RLAB's competition here
HNORY vs BWTL Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, BWTL has a market cap of 17.7M. Regarding current trading prices, HNORY is priced at $12.50, while BWTL trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas BWTL's P/E ratio is -21.25. In terms of profitability, HNORY's ROE is +0.08%, compared to BWTL's ROE of +0.01%. Regarding short-term risk, HNORY and BWTL have similar daily volatility (0.00).Check BWTL's competition here
HNORY vs EMCMF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, EMCMF has a market cap of 11.7M. Regarding current trading prices, HNORY is priced at $12.50, while EMCMF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas EMCMF's P/E ratio is -8.00. In terms of profitability, HNORY's ROE is +0.08%, compared to EMCMF's ROE of +0.07%. Regarding short-term risk, HNORY and EMCMF have similar daily volatility (0.00).Check EMCMF's competition here
HNORY vs NEXCF Comparison July 2025
HNORY plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HNORY stands at 3.1B. In comparison, NEXCF has a market cap of 11.5M. Regarding current trading prices, HNORY is priced at $12.50, while NEXCF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HNORY currently has a P/E ratio of 11.06, whereas NEXCF's P/E ratio is -1.55. In terms of profitability, HNORY's ROE is +0.08%, compared to NEXCF's ROE of -1.48%. Regarding short-term risk, HNORY is less volatile compared to NEXCF. This indicates potentially lower risk in terms of short-term price fluctuations for HNORY.Check NEXCF's competition here